Selectin Inhibitor
Showing 1 - 25 of 7,510
COVID-19 Pneumonia Trial in Ann Arbor (Uproleselan)
Recruiting
- COVID-19 Pneumonia
-
Ann Arbor, MichiganThe University of Michigan
Dec 6, 2021
sCD62L and SPARC in Chronic Myeloid Leukemia Patients During
Completed
- Chronic Myeloid Leukemia
- ELISA kit
-
Tanta, EgyptTanta University
May 18, 2022
Urologic Diseases, Erectile Dysfunction With Diabetes Trial in Jakarta Pusat (stem cells, )
Recruiting
- Urologic Diseases
- Erectile Dysfunction With Diabetes Mellitus
- stem cells
- placebo
-
Jakarta Pusat, DKI Jakarta, IndonesiaUniversitas Indonesia
Mar 28, 2022
Subclinical Impairment of Cardiovascular System in Psoriasis
Completed
- Psoriasis
- +6 more
-
Ljubljana, SloveniaUniversity Medical Centre Ljubljana
Jul 19, 2023
Clearance of Vasoactive Metabolites With Blood Purification
Not yet recruiting
- Critically Ill Patients
-
Garches, France
- +1 more
Oct 27, 2023
Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)
Recruiting
- Covid19
- theraputic heparin
- +4 more
-
Birmingham, Alabama
- +101 more
Jun 28, 2022
Cardiometabolic Health Trial in Kallithéa (Conventional fish, Enriched fish)
Completed
- Cardiometabolic Health
- Conventional fish
- Enriched fish
-
Kallithéa, Attica, GreeceDepartment of Nutrition and Dietetics, School of Health Sciences
Jun 9, 2022
DiabetesType 1 Trial (Placebo, Alpha Lipoic Acid 600 MG Oral Capsule)
Not yet recruiting
- Diabetes MellitusType 1
- Placebo
- Alpha Lipoic Acid 600 MG Oral Capsule
- (no location specified)
Jan 8, 2023
Sleep, Cardiovascular Risk Factor Trial in Portland (Regularized Sleep Schedule)
Recruiting
- Sleep
- Cardiovascular Risk Factor
- Regularized Sleep Schedule
-
Portland, OregonOregon Health and Science University
Aug 10, 2022
Coronary Artery Ectasia Trial (Rivaroxaban 2.5 Mg Oral Tablet twice daily, Clopidogrel 75 Mg Oral Tablet, Aspirin tablet 75 mg)
Not yet recruiting
- Coronary Artery Ectasia
- Rivaroxaban 2.5 Mg Oral Tablet twice daily
- +2 more
- (no location specified)
Jan 30, 2023
Inflammation Trial in Buffalo (Pioglitazone 15mg, pioglitazone 30mg, )
Completed
- Inflammation
- Pioglitazone 15mg
- +2 more
-
Buffalo, New YorkMillard Fillmore gates Hospital
Jan 12, 2022
Multiple Myeloma Trial in Saint Louis (Uproleselan, Placebo, Melphalan)
Completed
- Multiple Myeloma
- Uproleselan
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 22, 2022
Developmental Endothelial Locus-1, Platelet Count, and Soluble
Not yet recruiting
- Overweight and Obesity
- Platelet count
- +2 more
-
Aswan, EgyptAswan University Hospital
May 17, 2023
Coronary Artery Disease, Coronary Atherosclerosis, Nicotine Dependence Trial in Warsaw (heated tobacco - lifestyle intervention)
Not yet recruiting
- Coronary Artery Disease
- +2 more
- heated tobacco - lifestyle intervention
-
Warsaw, PolandNational Institute of Cardiology
Dec 27, 2022
Cardiac Implantable Electronic Devices on the Hemostatic System
Recruiting
- Thromboembolism
- +2 more
- Cardiac implantable electronic device implantation.
- +4 more
-
Ryazan', Ryazan, Russian FederationRyazan State Medical University
Oct 26, 2022
Acute Myelogenous Leukemia, MDS, Mixed Phenotype Acute Leukemia Trial (Fludarabine, Cytarabine, Uproleselan)
Not yet recruiting
- Acute Myelogenous Leukemia
- +2 more
- Fludarabine
- +2 more
- (no location specified)
Mar 3, 2022
Venous Insufficiency of Leg, Venous Insufficiency (Chronic)(Peripheral), Endothelial Dysfunction Trial in Moscow (Endovenous
Completed
- Venous Insufficiency of Leg
- +2 more
- Endovenous laser ablation of great saphenous vein (GSV) and microphlebectomy of varicose veins
- Pharmacotherapy
-
Moscow, Russian FederationN.I. Pirogov National Medical and Surgical Center
Sep 3, 2021
Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2 Trial in Sao Paulo (Janus Kinase Inhibitor (ruxolitinib), Placebo)
Terminated
- Severe Acute Respiratory Syndrome Coronavirus 2
- SARS-CoV2
- Janus Kinase Inhibitor (ruxolitinib)
- Placebo
-
Sao Paulo, BrazilHospital das Clínicas
Apr 5, 2021
Endometriosis Trial in Boston (norethindrone acetate (NETA), Placebo)
Not yet recruiting
- Endometriosis
- norethindrone acetate (NETA)
- Placebo
-
Boston, MassachusettsBoston Children's Hospital
Sep 14, 2022